AquaNab Solutions
PrivateLast Round
Early Funding
Aug 11, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
AquaNab Solutions is a biotechnology company that develops alpaca-derived nano-antibody therapeutics to control pathogenic infections in farmed salmon.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AquaNab Solutions Comparables
Compare AquaNab Solutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sundew Bio | 77% | |
| ViAqua Therapeutics | 76% | |
| FeedVax | 76% | |
AquaNab Solutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 11, 2026 |
AquaNab Solutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nordic Foodtech VC | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 11, 2026
Nordic Foodtech VC led the early funding round.
AquaNab Solutions Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AquaNab Solutions's valuation, stock price, and market status.